Inaugural Class of FDA-AACR Oncology Educational Fellows Announced
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the 2020-2021 class of FDA-AACR Oncology Educational Fellows....
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the 2020-2021 class of FDA-AACR Oncology Educational Fellows....
PHILADELPHIA – Among women participating in cervical cancer screening in Sweden, those with a diagnosis of invasive cervical cancer...
15 members of the AACR elected, including AACR President Antoni Ribas, MD, PhD PHILADELPHIA – The American Association for...
PHILADELPHIA – Baseline levels of circulating tumor DNA (ctDNA) predicted responses to first-line, but not second-line, immune checkpoint inhibition...
PHILADELPHIA – The histone deacetylase (HDAC) inhibitor vorinostat (Zolinza) in combination with the mTOR inhibitor sirolimus (Rapamune) or everolimus...
PHILADELPHIA – Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better sensitivity and...
PHILADELPHIA – The American Association for Cancer Research (AACR) congratulates Emmanuelle Charpentier, PhD, of the Max Planck Unit for...
PHILADELPHIA – The American Association for Cancer Research (AACR) has announced Lourdes A. Báezconde-Garbanati, PhD, as the recipient of...
PHILADELPHIA – Residents of counties that experience persistent poverty face a disproportionately high risk of cancer mortality, according to...
The report highlights record number of treatments approved by the FDA and cancer researchers’ role in fight against COVID-19...